AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37
PREVALENCE OF FACTOR-V-LEIDEN (APCR) AND OTHER INHERITED THROMBOPHILIAS IN YOUNG-PATIENTS WITH MYOCARDIAL-INFARCTION AND NORMAL CORONARY-ARTERIES
Authors: DACOSTA A TARDYPONCET B ISAAZ K CERISIER A MISMETTI P SIMITSIDIS S REYNAUD J TARDY B PIOT M DECOUSUS H GUYOTAT D
Citation: A. Dacosta et al., PREVALENCE OF FACTOR-V-LEIDEN (APCR) AND OTHER INHERITED THROMBOPHILIAS IN YOUNG-PATIENTS WITH MYOCARDIAL-INFARCTION AND NORMAL CORONARY-ARTERIES, HEART, 80(4), 1998, pp. 338-340
PHARMACOKINETIC AND PHARMACODYNAMIC VARIATIONS OF ACENOCOUMAROL ORALLY ADMINISTRATED EITHER ONCE OR TWICE-DAILY IN PATIENTS WITH DEEP VENOUS THROMBOSIS
Authors: MISMETTI P REYNAUD J LAPORTESIMITSIDIS S THIJSSEN H TARDYPONCET B TARDY B BUCHMULLER A DECOUSUS H
Citation: P. Mismetti et al., PHARMACOKINETIC AND PHARMACODYNAMIC VARIATIONS OF ACENOCOUMAROL ORALLY ADMINISTRATED EITHER ONCE OR TWICE-DAILY IN PATIENTS WITH DEEP VENOUS THROMBOSIS, Fundamental and clinical pharmacology, 12(6), 1998, pp. 631-635
AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-FACTOR XA AND ANTI-THROMBIN ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN)
Authors: MISMETTI P LAPORTESIMITSIDIS S NAVARRO C SIE P DAZEMAR P NECCIARI J DURET JP GAUD C DECOUSUS H BONEU B
Citation: P. Mismetti et al., AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-FACTOR XA AND ANTI-THROMBIN ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN), Thrombosis and haemostasis, 79(6), 1998, pp. 1162-1165
VENA-CAVAL FILTERS FOR THE PREVENTION OF PULMONARY-EMBOLISM - REPLY
Authors: DECOUSUS H MISMETTI P TARDY B
Citation: H. Decousus et al., VENA-CAVAL FILTERS FOR THE PREVENTION OF PULMONARY-EMBOLISM - REPLY, The New England journal of medicine, 339(1), 1998, pp. 47-48
INFLUENCE OF INTER-STUDY VARIABILITY IN POPULATION PHARMACOKINETIC METAANALYSIS
Authors: LAPORTE S GIRARD P MISMETTI P CHABAUD S
Citation: S. Laporte et al., INFLUENCE OF INTER-STUDY VARIABILITY IN POPULATION PHARMACOKINETIC METAANALYSIS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 118-118
SULBACTAM TREATMENT OF A SERRATIA-MARCESC ENS BACTEREMIA
Authors: PAGE Y AUBERT G TARDY B MISMETTI P PAUL G BERTRAND JC
Citation: Y. Page et al., SULBACTAM TREATMENT OF A SERRATIA-MARCESC ENS BACTEREMIA, Medecine et maladies infectieuses, 27, 1997, pp. 650-653
INDIVIDUALIZATION OF ANTITHROMBOTIC THERAPY FOR THE STROKE PREVENTIONIN NON RHEUMATISMAL ATRIAL-FIBRILLATION
Authors: MISMETTI P LAPORTE S GARNIER P TARDY B ANTOINE JC MICHEL D DECOUSUS H
Citation: P. Mismetti et al., INDIVIDUALIZATION OF ANTITHROMBOTIC THERAPY FOR THE STROKE PREVENTIONIN NON RHEUMATISMAL ATRIAL-FIBRILLATION, Thrombosis and haemostasis, 1997, pp. 358-358
ENDOGENOUS THROMBIN POTENTIAL AND HEPARIN MONITORING - IN-VITRO AND IN-VIVO STUDIES IN HEALTHY-VOLUNTEERS AND PATIENTS PRESENTING VENOUS THROMBOEMBOLISM
Authors: CAMBUS JP BEGUIN S MISMETTI P DECOUSUS H HEMKER HC BONEU B
Citation: Jp. Cambus et al., ENDOGENOUS THROMBIN POTENTIAL AND HEPARIN MONITORING - IN-VITRO AND IN-VIVO STUDIES IN HEALTHY-VOLUNTEERS AND PATIENTS PRESENTING VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 1997, pp. 1134-1134
AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-XA AND ANTI-IIA ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN)
Authors: BONEU B MISMETTI P LAPORTE S NAVARRO C SIE P DAZEMAR P NECCIARI J DURET JP GAUD C DECOUSUS H
Citation: B. Boneu et al., AGING AND VENOUS THROMBOEMBOLISM INFLUENCE THE PHARMACODYNAMICS OF THE ANTI-XA AND ANTI-IIA ACTIVITIES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARIN), Thrombosis and haemostasis, 1997, pp. 1149-1149
PREVALENCE OF FACTOR-V-LEIDEN AND OF OTHER INHERITED THROMBOPHILIA INYOUNG-PATIENTS UNDER 45 YEARS WITH MYOCARDIAL-INFARCTION AND NORMAL CORONARY-ARTERIES - A PROSPECTIVE-STUDY
Authors: DACOSTA A TARDYPONCET B ISAAZ K CERISIER A MISMETTI P SIMITSIDIS S RAYNAUD J TARDY B DECOUSUS H GUYOTAT D
Citation: A. Dacosta et al., PREVALENCE OF FACTOR-V-LEIDEN AND OF OTHER INHERITED THROMBOPHILIA INYOUNG-PATIENTS UNDER 45 YEARS WITH MYOCARDIAL-INFARCTION AND NORMAL CORONARY-ARTERIES - A PROSPECTIVE-STUDY, Thrombosis and haemostasis, 1997, pp. 1280-1280
FACTOR-V-LEIDEN AND ACUTE MYOCARDIAL-INFARCTION WITH NORMAL CORONARY-ARTERIES - A CASE-CONTROL STUDY
Authors: DACOSTA A TARDYPONCET B ISAAZ K CERISIER A MISMETTI P SIMITSIDIS S REYNAUD J BACHONGY P DECOUSUS H GUYOTAT D
Citation: A. Dacosta et al., FACTOR-V-LEIDEN AND ACUTE MYOCARDIAL-INFARCTION WITH NORMAL CORONARY-ARTERIES - A CASE-CONTROL STUDY, Thrombosis and haemostasis, 1997, pp. 1284-1284
INTERMEDIATE AND SURROGATE OUTCOMES IN CL INICAL-EVALUATION OF DRUGS
Authors: BOISSEL JP PERRET L BOUVENOT G CASTAIGNE A GERARDCOUE MJ MAILLERE P MISMETTI P VRAY M AVOUAC B BEGAUD B CAULIN C CHARPAK Y CHAUMETRIFFAUD P COSTAGLIOLA D DEGOS F DESTORS JM DOYON F FAGNANI F GIRI I GIRRE JP GOEHRS JM KHER A MOCCATTI D MUNOZ A DECURZON AP PLETAN Y ROY P VASMANT D WAJMAN A
Citation: Jp. Boissel et al., INTERMEDIATE AND SURROGATE OUTCOMES IN CL INICAL-EVALUATION OF DRUGS, Therapie, 52(4), 1997, pp. 281-285
HEPARINS AND CURATIVE TREATMENT OF VENOUS THROMBOEMBOLIC DISEASE - METAANALYSIS
Authors: MISMETTI P LAPORTESIMITSIDIS S LEIZOROVICZ A DECOUSUS H
Citation: P. Mismetti et al., HEPARINS AND CURATIVE TREATMENT OF VENOUS THROMBOEMBOLIC DISEASE - METAANALYSIS, Therapie, 52(1), 1997, pp. 47-52
EVOLUTION OF BLOOD-COAGULATION AND FIBRINOLYSIS PARAMETERS AFTER ABRUPT VERSUS GRADUAL WITHDRAWAL OF ACENOCOUMAROL IN PATIENTS WITH VENOUS THROMBOEMBOLISM - A DOUBLE-BLIND RANDOMIZED STUDY
Authors: TARDY B TARDYPONCET B LAPORTESIMITSIDIS S MISMETTI P DECOUSUS H GUYOTAT D BERTRAND JC
Citation: B. Tardy et al., EVOLUTION OF BLOOD-COAGULATION AND FIBRINOLYSIS PARAMETERS AFTER ABRUPT VERSUS GRADUAL WITHDRAWAL OF ACENOCOUMAROL IN PATIENTS WITH VENOUS THROMBOEMBOLISM - A DOUBLE-BLIND RANDOMIZED STUDY, British Journal of Haematology, 96(1), 1997, pp. 174-178
SYMPTOMATIC INFERIOR VENA-CAVA FILTER THROMBOSIS - CLINICAL-STUDY OF 30 CONSECUTIVE CASES
Authors: TARDY B MISMETTI P PAGE Y DECOUSUS H DACOSTA A ZENI F BARRAL G BERTRAND JC
Citation: B. Tardy et al., SYMPTOMATIC INFERIOR VENA-CAVA FILTER THROMBOSIS - CLINICAL-STUDY OF 30 CONSECUTIVE CASES, The European respiratory journal, 9(10), 1996, pp. 2012-2016
ORG-10172 FOR HEPARIN-INDUCED THROMBOCYTO PENIA - TOLERANCE AND EFFICACY
Authors: TARDYPONCET B REYNAUD J TARDY B MAHUL P MISMETTI P BERAUD AM REBAUD MA BAYON M GUYOTAT D
Citation: B. Tardyponcet et al., ORG-10172 FOR HEPARIN-INDUCED THROMBOCYTO PENIA - TOLERANCE AND EFFICACY, La Presse medicale, 25(16), 1996, pp. 751-755
DETERMINING THE OPTIMAL DOSE OF ANTITHROM BOTIC AGENTS
Authors: MISMETTI P LAPORTESIMITSIDIS S DECOUSUS H
Citation: P. Mismetti et al., DETERMINING THE OPTIMAL DOSE OF ANTITHROM BOTIC AGENTS, Archives des maladies du coeur et des vaisseaux, 89(11), 1996, pp. 1473-1477
INFLAMMATORY PSEUDO-TUMOR OF THE BOWEL CA USED BY A NECROSING VASCULITIS DURING HORTONS-DISEASE
Authors: FONTANEY F DACOSTA A MOSNIER JF PORCHERON J MISMETTI P BOUCHOU K ROUSSET H DECOUSUS H
Citation: F. Fontaney et al., INFLAMMATORY PSEUDO-TUMOR OF THE BOWEL CA USED BY A NECROSING VASCULITIS DURING HORTONS-DISEASE, Gastroenterologie clinique et biologique, 19(11), 1995, pp. 940-943
CHRONO-PHARMACOLOGICAL STUDY OF ONCE-DAILY CURATIVE DOSE OF A LOW-MOLECULAR-WEIGHT HEPARIN (200 IU ANTIXA KG OF DALTEPARIN) IN 10 HEALTHY-VOLUNTEERS/
Authors: MISMETTI P REYNAUD J TARDYPONCET B LAPORTESIMITSIDIS S SCULLY M GOODWYN C QUENEAU P DECOUSUS H
Citation: P. Mismetti et al., CHRONO-PHARMACOLOGICAL STUDY OF ONCE-DAILY CURATIVE DOSE OF A LOW-MOLECULAR-WEIGHT HEPARIN (200 IU ANTIXA KG OF DALTEPARIN) IN 10 HEALTHY-VOLUNTEERS/, Thrombosis and haemostasis, 74(2), 1995, pp. 660-666
PREDICTIVE NADROPARIN CALCIUM (FRAXIPARIN(R)) DOSAGE REGIMENS IN NEONATES AND CHILDREN AFTER CARDIOVASCULAR-SURGERY
Authors: MISMETTI P PIQUET P LAPORTESIMITSIDIS S DOUBINE S TOUCHOT A DECOUSUS H
Citation: P. Mismetti et al., PREDICTIVE NADROPARIN CALCIUM (FRAXIPARIN(R)) DOSAGE REGIMENS IN NEONATES AND CHILDREN AFTER CARDIOVASCULAR-SURGERY, Thrombosis and haemostasis, 73(6), 1995, pp. 968-968
PREDICTIVE ENOXAPARIN (LOVENOX(R) DOSAGE REGIMENS IN NEONATES AND CHILDREN AFTER CARDIOVASCULAR-SURGERY
Authors: PIQUET P LAPORTESIMITSIDIS S DOUBINE S MISMETTI P HOUYEL L DECOUSUS H
Citation: P. Piquet et al., PREDICTIVE ENOXAPARIN (LOVENOX(R) DOSAGE REGIMENS IN NEONATES AND CHILDREN AFTER CARDIOVASCULAR-SURGERY, Thrombosis and haemostasis, 73(6), 1995, pp. 972-972
PHARMACOKINETIC-PHARMACODYNAMIC MODEL OF ACENOCOUMAROL EVALUATED BY PROTHROMBIN TIME AND DE CARBOXY PROTHROMBIN (PIVKA-II)
Authors: MISMETTI P DACOSTA A LAPORTESIMITSIDIS S TARDY B GAV JP MERLE O DECOUSUS H
Citation: P. Mismetti et al., PHARMACOKINETIC-PHARMACODYNAMIC MODEL OF ACENOCOUMAROL EVALUATED BY PROTHROMBIN TIME AND DE CARBOXY PROTHROMBIN (PIVKA-II), Thrombosis and haemostasis, 73(6), 1995, pp. 1111-1111
ABRUPT VERSUS GRADUAL WITHDRAWAL OF ACENOCOUMAROL IN VENOUS THROMBOEMBOLIC DISEASE - A DOUBLE-BLIND RANDOMIZED STUDY
Authors: TARDY B TARDYPONCET B SIMITSIDIS S DECOUSUS H MISMETTI P LEIZOROVICZ A BERTRAND JC GUYOTAT D
Citation: B. Tardy et al., ABRUPT VERSUS GRADUAL WITHDRAWAL OF ACENOCOUMAROL IN VENOUS THROMBOEMBOLIC DISEASE - A DOUBLE-BLIND RANDOMIZED STUDY, Thrombosis and haemostasis, 73(6), 1995, pp. 1119-1119
EFFICACY AND SAFETY OF ORGARAN ANTICOAGULATION IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA
Authors: TARDYPONCET B REYNAUD J TARDY B MAHUL P MISMETTI P DECOUSUS H GUYOTAT D
Citation: B. Tardyponcet et al., EFFICACY AND SAFETY OF ORGARAN ANTICOAGULATION IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA, Thrombosis and haemostasis, 73(6), 1995, pp. 1323-1323
INFLUENCE OF CONFOUNDING FACTORS ON DESIGNS FOR DOSE-EFFECT RELATIONSHIP ESTIMATES
Authors: GIRARD P LAPORTESIMITSIDIS S MISMETTI P DECOUSUS H BOISSEL JP
Citation: P. Girard et al., INFLUENCE OF CONFOUNDING FACTORS ON DESIGNS FOR DOSE-EFFECT RELATIONSHIP ESTIMATES, Statistics in medicine, 14(9-10), 1995, pp. 987-1005
Risultati: 1-25 | 26-37